A newly developed single blood test has the potential to change the way doctors screen for cancer, researchers have said.
Scientists at Johns Hopkins University in the US have developed a test that screens for eight common forms of cancer and helps identify the location of the disease.
The test, called CancerSEEK, looks for mutations in 16 genes and evaluates the levels of eight proteins usually released by cancer sufferers.
The test, called CancerSEEK, looks for mutations in 16 genes and evaluates the levels of eight proteins usually released by cancer sufferers
The researchers said overall the test's ability to find cancers was successful 70% of the time – and ranged from a high of 98% for ovarian cancer to a low of 33% for breast cancer.
Nickolas Papadopoulos, senior author and professor of oncology and pathology, said: 'The use of a combination of selected biomarkers for early detection has the potential to change the way we screen for cancer, and it is based on the same rationale for using combinations of drugs to treat cancers.'
Cristian Tomasetti, associate professor of oncology and